Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,132 Diabetes
clinical trials

Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
2126
mi
from 91732
Brooksville, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
686
mi
from 91732
El Paso, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
1194
mi
from 91732
Fort Worth, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Status: Enrolling, Phase III
Updated: 7/6/2015
Clinical Research Facility
2304
mi
from 91732
West Palm Beach, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
379
mi
from 91732
Lincoln, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
661
mi
from 91732
Nampa, ID
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
1164
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
1300
mi
from 91732
Omaha, NE
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
2306
mi
from 91732
Pembroke Pines, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
2267
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
570
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
2268
mi
from 91732
South Chesterfield, VA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
MK-8835/PF-04971729 vs. Glimepiride in Type 2 Diabetes Mellitus (T2DM) Participants on Metformin (MK-8835-002)
Status: Enrolling, Phase III
Updated: 2/4/2015
Clinical Research Facility
25
mi
from 91732
Tustin, CA
Click here to add this to my saved trials
Glycogen Storage Disease Type II Pompe Disease Clinical Trial
NeoGAA Extension Study
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Clinical Research Facility
1573
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
2318
mi
from 91732
Coral Gables, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
367
mi
from 91732
Greenbrae, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
1919
mi
from 91732
Roswell, GA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Safety and Efficacy of Ertugliflozin in the Treatment of Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin and Sitagliptin (MK-8835-006)
Status: Enrolling, Phase III
Updated: 2/25/2015
Clinical Research Facility
20
mi
from 91732
Upland, CA
Click here to add this to my saved trials
Endocrinology Clinical Trial
The WISE (Weightloss Intervention Surgical Effects) Brain Study
Status: Enrolling, Phase
Updated: 12/31/1969
University of Florida - College of Public Health and Health Professions
2104
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
19
mi
from 91732
Chino, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
686
mi
from 91732
El Paso, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
1932
mi
from 91732
Perrysburg, OH
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
109
mi
from 91732
Spring Valley, CA
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
Memorial Hermann South West
1350
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
The Center for Wound Healing Cabell Huntington Hospital
1993
mi
from 91732
Huntington, WV
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
St. Luke's Wound and Hyperbaric Center
664
mi
from 91732
Meridian, ID
Click here to add this to my saved trials
Diabetic Foot Ulcers Clinical Trial
Effectiveness of Aurix Therapy in Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 1/23/2018
The Wound Center of Niagara
2173
mi
from 91732
Niagara Falls, NY
Click here to add this to my saved trials
Neuropathic Diabetic Ulcer - Foot Clinical Trial
A Multi-Center, Prospective, Open Label Safety Trial of the RedDress Wound Care System (RD1) in Management of Texas 1a or 2a Neuropathic Diabetic Foot Ulcers.
Status: Enrolling, Phase II
Updated: 4/5/2016
Amun Research
2307
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Pre-Diabetes Clinical Trial
Improving Beta Cell Function in Mexican American Women With Prediabetes
Status: Enrolling, Phase IV
Updated: 4/3/2018
Denver Harbor Multi-service Center
1358
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
1780
mi
from 91732
Avon, IN
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
356
mi
from 91732
Chandler, AZ
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
1422
mi
from 91732
Des Moines, IA
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Call for Information (Investigational Site 0128)
1283
mi
from 91732
La Joya, TX
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
2245
mi
from 91732
Rochester, NY
Click here to add this to my saved trials
Type II Diabetes Mellitus Clinical Trial
A Preliminary Study of the Efficacy and Safety of MK-8521 for Type 2 Diabetes (MK-8521-004)
Status: Enrolling, Phase II
Updated: 12/29/2016
Clinical Research Facility
2126
mi
from 91732
Winston-Salem, NC
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
2103
mi
from 91732
Gainesville, FL
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Afrezza Safety and Pharmacokinetics Study in Pediatric Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
208
mi
from 91732
Las Vegas, NV
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
2104
mi
from 91732
Columbia, SC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
25
mi
from 91732
Harbor City, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
2361
mi
from 91732
Harleysville, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
1564
mi
from 91732
Hazelwood, MO
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
33
mi
from 91732
Irvine, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
1647
mi
from 91732
Mandeville, LA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
2114
mi
from 91732
McMurray, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
2324
mi
from 91732
Miami Beach, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
1725
mi
from 91732
Muscle Shoals, AL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
364
mi
from 91732
Sacramento, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
2118
mi
from 91732
Salisbury, NC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
338
mi
from 91732
San Ramon, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
1933
mi
from 91732
Suwanee, GA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Failure
Status: Enrolling, Phase III
Updated: 12/9/2015
Clinical Research Facility
2275
mi
from 91732
Wilmington, NC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
2102
mi
from 91732
Clarksburg, WV
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
1920
mi
from 91732
Dunwoody, GA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
1959
mi
from 91732
Franklin, OH
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
2029
mi
from 91732
Greer, SC
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
13
mi
from 91732
Huntington Park, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
25
mi
from 91732
Lomita, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
21
mi
from 91732
Long Beach, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
1237
mi
from 91732
Manhattan, KS
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
2363
mi
from 91732
Media, PA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
1586
mi
from 91732
Memphis, TN
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
1164
mi
from 91732
Oklahoma City, OK
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
27
mi
from 91732
Redondo Beach, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
2196
mi
from 91732
Saint Cloud, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
314
mi
from 91732
San Jose, CA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/1/2015
Clinical Research Facility
1182
mi
from 91732
Wichita, KS
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2321
mi
from 91732
Miami, FL
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2486
mi
from 91732
New Haven, CT
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
364
mi
from 91732
Sacramento, CA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1930
mi
from 91732
Stockbridge, GA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
TODAY2 Phase 2 Follow-up
Status: Enrolling, Phase
Updated: 2/28/2018
SUNY Upstate New York University
2320
mi
from 91732
Syracuse, NY
Click here to add this to my saved trials
Pompe Disease Clinical Trial
First-In-Human Study to Evaluate Safety, Tolerability, and PK of Intravenous ATB200 Alone and When Co-Administered With Oral AT2221
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Women's and Children's Hospital-Adelaide
8190
mi
from 91732
North Adelaide,
Click here to add this to my saved trials
Foot Ulcer, Diabetic Clinical Trial
GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 4/4/2017
Clinical Research Facility
373
mi
from 91732
California, CA
Click here to add this to my saved trials
Foot Ulcer, Diabetic Clinical Trial
GrafixPRIME® for the Treatment of Chronic Diabetic Foot Ulcers
Status: Enrolling, Phase IV
Updated: 4/4/2017
Clinical Research Facility
693
mi
from 91732
New Mexico, NM
Click here to add this to my saved trials
Endocrinology Clinical Trial
The Management of Diabetes in Everyday Life Program
Status: Enrolling
Updated: 11/17/2016
Hawkins Family Medicine
1636
mi
from 91732
Holly Springs, MS
Click here to add this to my saved trials
Endocrinology Clinical Trial
The Management of Diabetes in Everyday Life Program
Status: Enrolling
Updated: 11/17/2016
Christ Community Health Center - Raleigh Health Center
1593
mi
from 91732
Memphis, TN
Click here to add this to my saved trials
Diabetes Clinical Trial
Health Literacy Intervention to Improve Diabetes Outcomes Among Rural Primary Care Patients
Status: Enrolling
Updated: 12/31/1969
UAMS Family Medical Center Jonesboro
1546
mi
from 91732
Jonesboro, AR
Click here to add this to my saved trials
Diabetes Clinical Trial
Health Literacy Intervention to Improve Diabetes Outcomes Among Rural Primary Care Patients
Status: Enrolling
Updated: 12/31/1969
UAMS Family Medical Center Pine Bluff
1482
mi
from 91732
Pine Bluff, AR
Click here to add this to my saved trials
Diabetes Mellitus, Type 2 Clinical Trial
Phase 3 Alogliptin Pediatric Study
Status: Enrolling, Phase III
Updated: 12/31/1969
Endocrine Consultants Research
1902
mi
from 91732
Columbus, GA
Click here to add this to my saved trials
Type 2 Diabetes Clinical Trial
A Study of Dulaglutide (LY2189265) in Children and Adolescents With Type 2 Diabetes
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Center for Endocrinology & Metabolism
2184
mi
from 91732
Orlando, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1729
mi
from 91732
Chicago, IL
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2269
mi
from 91732
Fairfax, VA
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
1511
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2122
mi
from 91732
Morgantown, WV
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2119
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Glycogen Storage Disease Type II-Pompe's Disease Clinical Trial
Study to Compare the Efficacy and Safety of Enzyme Replacement Therapies neoGAA and Alglucosidase Alfa Administered Every Other Week in Patients With Late-onset Pompe Disease Who Have Not Been Previously Treated for Pompe Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
2443
mi
from 91732
Valhalla, NY
Click here to add this to my saved trials
Diabetes Mellitus Clinical Trial
Hyperbaric Oxygen Therapy for Cognition in Diabetic Elderly at High Dementia Risk
Status: Enrolling
Updated: 12/31/1969
Sheba Medical Center
7538
mi
from 91732
Ramat Gan,
Click here to add this to my saved trials
Type 1 Diabetes Mellitus Clinical Trial
Extension Study to Assess Safety and Efficacy of Mylan's Insulin Glargine and Lantus® in Type 1 Diabetes Mellitus Patients
Status: Enrolling, Phase III
Updated: 1/25/2016
Mylan Investigator Site
1208
mi
from 91732
Austin, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Lynn Institute of Denver
820
mi
from 91732
Aurora, CO
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT)
Status: Enrolling, Phase III
Updated: 12/31/1969
Spectrum Clinical Research
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
1 … 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 … 41